Theravance Biopharma Inc (TBPH)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN, CAYMAN ISLANDS KY1-1104

Theravance Biopharma Inc focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system.

Data as of 2020-06-06
Market Cap1.63 Billion Shares Outstanding63.088 Million Avg 30-day Volume336.219 Thousand
P/E Ratio Dividend Yield EPS-4.34
Price/Sales18.538 Price cash flow ratio Price free cash flow ratio-7.9
Book Value-2.5 Price to Tangible Book-10.51 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.161131
BETA1.42175 52-week High/Low31.54 / 15.35 Stddev0.152045
View SEC Filings from TBPH instead.

View recent insider trading info

Funds Holding TBPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TBPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SMALDONE ALSUP LAURIE

  • Director
0 2020-06-03 1

YOUNG WILLIAM D

  • Director
0 2020-06-01 1

HAUMANN BRETT K

  • Director
19,563 2020-05-27 5

GLAXOSMITHKLINE PLC

  • Director
2,253,660 2020-05-21 0

WINNINGHAM RICK E CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,395,628 2020-05-20 5

PASQUALONE FRANK SVP, CHIEF COMM OPS OFFICER

  • Officer
410,108 2020-05-20 5

ATIEH MICHAEL G

  • Director
40,041 2020-05-20 0

SHAFER BRADFORD J EVP, GEN. COUNSEL, SECRETARY

  • Officer
261,527 2020-05-20 5

WORBOYS PHILIP D SVP, RESEARCH & TRANSL SCIENCE

  • Officer
350,355 2020-05-20 5

PITZER KENNETH R SVP, PROD STRAT & COMM PLNG

  • Officer
344,891 2020-05-20 5

SABESAN VIJAY SVP, TECHNICAL OPERATIONS

  • Officer
200,641 2020-05-20 6

BRADY ANN PRESIDENT, TBIL

  • Officer
102,871 2020-05-20 5

O'CONNOR DONAL

  • Director
11,635 2020-05-15 1

GALA RENEE D EVP & CFO

  • Officer
16,600 2020-05-07 0

WHITESIDES GEORGE M

  • Director
55,064 2020-05-05 1

GUNDERSON ROBERT V JR

  • Director
69,112 2020-04-28 1

MALKIEL BURTON G

  • Director
86,777 2020-04-28 1

MITCHELL DEAN J

  • Director
41,206 2020-04-28 1

BROSHY ERAN

  • Director
41,206 2020-04-28 1

MOLINEAUX SUSAN

  • Director
41,206 2020-04-28 1

INNOVIVA, INC.

  • 10% Owner
1,322,510 2020-04-22 0

HINDMAN ANDREW A. SVP, CHIEF FINANCIAL OFFICER

  • Officer
106,490 2020-02-20 3

SULIMAN SHEHNAAZ PRESIDENT AND COO

  • Officer
0 2020-01-01 0

MAMMEN MATHAI

  • Director
0 2019-09-16 0

HEGDE SHARATHCHANDRA S SVP, RESEARCH

  • Officer
259,900 2019-08-20 1

RINGROSE PETER S

  • Director
37,999 2019-04-30 0

BLUM LEONARD M SEE REMARKS

  • Officer
0 2018-05-14 0

FORE HENRIETTA

  • Director
No longer subject to file 2017-12-31 0

LEE JUNNING SR. VP, TECHNICAL OPERATIONS

  • Officer
234,071 2017-02-20 0

JONKER JEFFREY DAVID SENIOR VP, CORP. & BUS. DEV.

  • Officer
0 2014-06-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PASQUALONE FRANK - Officer SVP, CHIEF COMM OPS OFFICER

2020-05-20 F 4,214 $26.67 d 410,108 410,108.00 direct

SHAFER BRADFORD J - Officer EVP, GEN. COUNSEL, SECRETARY

2020-05-20 F 4,807 $26.67 d 261,527 261,527.00 direct

BRADY ANN - Officer PRESIDENT, TBIL

2020-05-20 F 2,292 $26.67 d 102,871 102,871.00 direct

PITZER KENNETH R - Officer SVP, PROD STRAT & COMM PLNG

2020-05-20 F 4,807 $26.67 d 344,891 344,891.00 direct

WINNINGHAM RICK E - Director - Officer CHIEF EXECUTIVE OFFICER

2020-05-20 F 13,946 $26.67 d 1,303,061 1,395,628.00 direct

HAUMANN BRETT K - Officer SVP CLIN DEV & CHIEF MED OFC

2020-05-20 F 4,212 $26.67 d 312,456 312,456.00 direct

SABESAN VIJAY - Officer SVP, TECHNICAL OPERATIONS

2020-05-20 F 3,801 $26.67 d 200,641 200,641.00 direct

WORBOYS PHILIP D - Officer SVP, RESEARCH & TRANSL SCIENCE

2020-05-20 F 4,807 $26.67 d 350,355 350,355.00 direct

MITCHELL DEAN J - Director

2020-04-28 A 6,635 a 41,206 41,206.00 direct

WHITESIDES GEORGE M - Director

2020-04-28 A 6,000 a 6,000 239,248.00 direct

MOLINEAUX SUSAN - Director

2020-04-28 A 6,635 a 6,635 41,206.00 direct

YOUNG WILLIAM D - Director

2020-04-28 A 6,000 a 6,000 58,330.00 direct

SMALDONE ALSUP LAURIE - Director

2020-04-28 A 6,635 a 24,982 24,982.00 direct

GUNDERSON ROBERT V JR - Director

2020-04-28 A 6,000 a 6,000 69,112.00 direct

MALKIEL BURTON G - Director

2020-04-28 A 6,635 a 71,777 86,777.00 direct

WHITESIDES GEORGE M - Director

2020-04-28 A 6,635 a 6,635 239,248.00 direct

O'CONNOR DONAL - Director

2020-04-28 A 6,000 a 6,000 34,206.00 direct

YOUNG WILLIAM D - Director

2020-04-28 A 6,635 a 58,330 58,330.00 direct

BROSHY ERAN - Director

2020-04-28 A 6,000 a 6,000 41,206.00 direct

GUNDERSON ROBERT V JR - Director

2020-04-28 A 6,635 a 58,265 69,112.00 direct

MITCHELL DEAN J - Director

2020-04-28 A 6,000 a 6,000 41,206.00 direct

MOLINEAUX SUSAN - Director

2020-04-28 A 6,000 a 6,000 41,206.00 direct

O'CONNOR DONAL - Director

2020-04-28 A 6,635 a 34,206 34,206.00 direct

SMALDONE ALSUP LAURIE - Director

2020-04-28 A 6,000 a 6,000 24,982.00 direct

BROSHY ERAN - Director

2020-04-28 A 6,635 a 41,206 41,206.00 direct

MALKIEL BURTON G - Director

2020-04-28 A 6,000 a 6,000 86,777.00 direct

Elevate your investments